Claypoole Robert E bought BVS
March 13, 2026 · Form 4 insider transaction
Claypoole Robert E bought 33,500 shares of Bioventus Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
33,500
Price
$0.00
Total value
N/A
InsiderClaypoole Robert E
Role—
CompanyBioventus Inc. (BVS)
SecurityClass A Common Stock
Transaction codeM: Option exercise
Transaction dateMarch 13, 2026
Filing dateMarch 17, 2026
Shares owned after150,497
OwnershipDirect
10b5-1 planNo
AmendedNo